Cargando...
Considerations for a Pediatric Biopharmaceutics Classification System (BCS): Application to Five Drugs
It has been advocated that biopharmaceutic risk assessment should be conducted early in pediatric product development and synchronized with the adult product development program. However, we are unaware of efforts to classify drugs into a Biopharmaceutics Classification System (BCS) framework for pe...
Gardado en:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4037489/ https://ncbi.nlm.nih.gov/pubmed/24557773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-014-0084-0 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|